| Pharmaceutical Information |
| Drug Name |
Tenoxicam |
| Drug ID |
BADD_D02157 |
| Description |
Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain. |
| Indications and Usage |
For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain. |
| Marketing Status |
Not Available |
| ATC Code |
M01AC02 |
| DrugBank ID |
DB00469
|
| KEGG ID |
D01767
|
| MeSH ID |
C032801
|
| PubChem ID |
54677971
|
| TTD Drug ID |
D0I6IB
|
| NDC Product Code |
17337-0542 |
| Synonyms |
tenoxicam | 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide | Ro 12-0068 | Ro-12-0068 | Reutenox | Artriunic | Novo-Tenoxicam | Mobiflex | Tilcotil | Apo-Tenoxicam |
|
| Chemical Information |
| Molecular Formula |
C13H11N3O4S2 |
| CAS Registry Number |
59804-37-4 |
| SMILES |
CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
